Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients
- PMID: 36203411
- PMCID: PMC10078135
- DOI: 10.1111/eci.13887
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients
Abstract
Background: Lung hyperinflation and systemic inflammation are currently believed to be the most important causes of right heart alterations in chronic obstructive pulmonary disease (COPD) patients. A multicentre observational study was performed to assess the morphological and functional parameters of right ventricle (RV) in COPD subjects, as well as to evaluate the potential prognostic impact on the development of major cardiovascular adverse events (MACEs).
Methods: For this retrospective study, from 1 January 2010 to 31 December 2021, we enrolled COPD patients on the basis of their airflow limitation. In particular, we selected subjects spanning across GOLD 1 and 2 functional stages. Clinical, laboratory and functional parameters were collected at baseline. Echocardiography was routinely performed in all COPD patients. RV dysfunction was defined on the basis of tricuspid annular plane systolic excursion (TAPSE) values. MACE occurrence (non-fatal ischemic stroke, non-fatal myocardial infarction, cardiac revascularization or coronary bypass surgery and cardiovascular death) was evaluated during a median follow-up of 55 (36-72) months.
Results: Among the 749 enrolled patients, 408 subjects had a TAPSE value ≥20 mm, while the remaining 341 had a TAPSE value <20 mm. In patients with TAPSE ≥20 mm the observed MACEs were 1.9 events/100 patient-year, while in the group with a worse right heart function there were 4.2 events/100 patient-year (p < .0001). The multivariate analysis model confirmed the association between RV dysfunction and MACE. Indeed, a 1-mm increase in TAPSE value and the intake of long-acting β2 -receptor agonists (LABA)/long-acting muscarinic antagonist (LAMA) inhaled therapy were protective factors for the onset of MACE, while the presence of diabetes mellitus and high values of both uric acid (UA) and systolic pulmonary arterial pressure (S-PAP) enhanced the risk of MACE in study participants.
Conclusions: The results of this study showed that in patients with mild COPD there is an association between right heart dysfunction and the risk of MACE during follow-up.
Keywords: COPD; MACE; TAPSE; oxidative stress; right heart.
© 2022 The Authors. European Journal of Clinical Investigation published by John Wiley & Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures





Similar articles
-
ST-Segment Elevation Myocardial Infarction in Patients With Chronic Obstructive Pulmonary Disease: Prognostic Implications of Right Ventricular Systolic Dysfunction as Assessed with Two-Dimensional Speckle-Tracking Echocardiography.J Am Soc Echocardiogr. 2019 Oct;32(10):1277-1285. doi: 10.1016/j.echo.2019.05.016. Epub 2019 Jul 13. J Am Soc Echocardiogr. 2019. PMID: 31311703
-
Impaired RV global longitudinal strain is associated with poor long-term clinical outcomes in patients with acute inferior STEMI.JACC Cardiovasc Imaging. 2015 Feb;8(2):161-9. doi: 10.1016/j.jcmg.2014.10.011. Epub 2015 Jan 7. JACC Cardiovasc Imaging. 2015. PMID: 25577444
-
Prognostic Value of Right Ventricular Function Assessed by Echocardiography in Patients With Acute Inferior ST Elevation Myocardial Infarction.Echocardiography. 2025 Jun;42(6):e70223. doi: 10.1111/echo.70223. Echocardiography. 2025. PMID: 40536072
-
TAPSE: An old but useful tool in different diseases.Int J Cardiol. 2016 Dec 15;225:177-183. doi: 10.1016/j.ijcard.2016.10.009. Epub 2016 Oct 5. Int J Cardiol. 2016. PMID: 27728861 Review.
-
Tricuspid annular plane systolic excursion (TAPSE) measured by echocardiography and mortality in COVID-19: A systematic review and meta-analysis.Int J Infect Dis. 2021 Apr;105:351-356. doi: 10.1016/j.ijid.2021.02.029. Epub 2021 Feb 11. Int J Infect Dis. 2021. PMID: 33582370 Free PMC article.
Cited by
-
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study.Int J Chron Obstruct Pulmon Dis. 2023 May 26;18:995-1002. doi: 10.2147/COPD.S407238. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37260547 Free PMC article.
-
The characteristics and outcomes in patients with acute heart failure who used tolvaptan: from KCHF registry.ESC Heart Fail. 2023 Oct;10(5):3141-3151. doi: 10.1002/ehf2.14494. Epub 2023 Aug 29. ESC Heart Fail. 2023. PMID: 37644779 Free PMC article.
-
Impact of comorbidities in COPD clinical control criteria. The CLAVE study.BMC Pulm Med. 2024 Jan 2;24(1):6. doi: 10.1186/s12890-023-02758-0. BMC Pulm Med. 2024. PMID: 38166965 Free PMC article.
-
Efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension patients with pulmonary comorbidity.Int J Cardiol Heart Vasc. 2024 Feb 29;51:101363. doi: 10.1016/j.ijcha.2024.101363. eCollection 2024 Apr. Int J Cardiol Heart Vasc. 2024. PMID: 38445233 Free PMC article.
-
Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension.J Clin Med. 2023 Aug 23;12(17):5472. doi: 10.3390/jcm12175472. J Clin Med. 2023. PMID: 37685538 Free PMC article.
References
-
- Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931‐1940. - PubMed
-
- Global Strategy for the Diagnosis Management and Prevention of COPD . Global initiative for chronic obstructive lung disease (GOLD). 2022. http://www.goldcopd.org/. Accessed July 1, 2022.
-
- Blanco I, Diego I, Bueno P, Casas‐Maldonado F, Miravitlles M. Geographic distribution of COPD prevalence in the world displayed by geographic Information system maps. Eur Respir J. 2019;54(1):1900610. - PubMed
-
- Wood‐Baker R, Cochrane B, Naughton MT. Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment. Intern Med J. 2010;40(2):94‐101. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials